{"DataElement":{"publicId":"3278753","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy Small Cell Lung Carcinoma Status Type","preferredDefinition":"A description of the best response to therapy for small cell lung carcinoma.","longName":"2946463v1.0:3278722v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2946463","version":"1","preferredName":"Disease or Disorder Best Outcome of Therapy","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Having the most positive qualities._The result of therapy for a given disease or condition in a patient or group of patients.","longName":"2404658v1.0:3194600v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3194600","version":"1","preferredName":"Best Outcome of Therapy","preferredDefinition":"Having the most positive qualities.:The result of therapy for a given disease or condition in a patient or group of patients.","longName":"C25432:C18919","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Best","conceptCode":"C25432","definition":"Having the most positive qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome of Therapy","conceptCode":"C18919","definition":"The result of therapy for a given disease or condition in a patient or group of patients.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D80CD45-BE7A-5B19-E040-BB89AD430E80","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-03-02","modifiedBy":"ONEDATA","dateModified":"2011-03-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"747EBAC6-25E8-A734-E040-BB89AD43588E","latestVersionIndicator":"Yes","beginDate":"2009-09-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3278722","version":"1","preferredName":"Small Cell Lung Carcinoma Status Type","preferredDefinition":"A highly aggressive subtype of lung carcinoma characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis._A condition or state at a particular time._Type; a subdivision of a particular kind of thing.","longName":"3278722v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No response / stable disease","valueDescription":"No response / stable disease","ValueMeaning":{"publicId":"3278724","version":"1","preferredName":"No response / stable disease","longName":"3278724","preferredDefinition":"No new lesions;  less than 50 percent reduction but less than 25 percent increase in any existing lesion.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD00CE93-1BA8-1C82-E040-BB89AD436E31","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD00CE93-1BC0-1C82-E040-BB89AD436E31","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Partial response","valueDescription":"Partial response","ValueMeaning":{"publicId":"3278725","version":"1","preferredName":"Partial response","longName":"3278725","preferredDefinition":"Primary tumor decreased by  greater than or equal to 50 percent; all measurable metastatic sites decreased by greater than 50 percent.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD00CE93-1BCA-1C82-E040-BB89AD436E31","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD00CE93-1BE2-1C82-E040-BB89AD436E31","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Very good partial response","valueDescription":"Very good partial response","ValueMeaning":{"publicId":"3278726","version":"1","preferredName":"Very good partial response","longName":"3278726v1.00","preferredDefinition":"Partial response with additional serum and urine M-protein reduction, but not meeting complete response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Very Good Partial Response","conceptCode":"C123618","definition":"Partial response with additional serum and urine M-protein reduction, but not meeting complete response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD00CE93-1BEC-1C82-E040-BB89AD436E31","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"KUMMEROA","dateModified":"2023-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD00CE93-1C04-1C82-E040-BB89AD436E31","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Complete response","valueDescription":"Complete response","ValueMeaning":{"publicId":"3263658","version":"1","preferredName":"Complete response","longName":"3263658","preferredDefinition":"No primary tumor, no metastatic sites, catecholamines normal","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB461F5D-3E91-78CA-E040-BB89AD434E2B","latestVersionIndicator":"Yes","beginDate":"2011-08-24","endDate":null,"createdBy":"SORENSENS","dateCreated":"2011-08-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD00CE93-1C0E-1C82-E040-BB89AD436E31","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Not assessed","valueDescription":"Negation Assessment","ValueMeaning":{"publicId":"3049794","version":"1","preferredName":"Negation Assessment","longName":"3049794","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Having determined the value, significance, or extent of.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"836E0020-994D-2647-E040-BB89AD435E03","latestVersionIndicator":"Yes","beginDate":"2010-04-04","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2010-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AD00CE93-1C25-1C82-E040-BB89AD436E31","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","deletedIndicator":"No"},{"value":"Relapse from complete remission","valueDescription":"Recurrent Disease","ValueMeaning":{"publicId":"3285249","version":"1","preferredName":"Recurrent Disease","longName":"3285249","preferredDefinition":"the return of a sign, symptom, or disease after a remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ADDD27F0-8D3B-9E51-E040-BB89AD43028A","latestVersionIndicator":"Yes","beginDate":"2011-09-26","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-09-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2045A13-8283-ADB5-E040-BB89AD4374D9","beginDate":"2011-11-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-11-18","modifiedBy":"ONEDATA","dateModified":"2011-11-18","deletedIndicator":"No"},{"value":"No disease treatment","valueDescription":"Negation Therapeutic Procedure","ValueMeaning":{"publicId":"3308097","version":"1","preferredName":"Negation Therapeutic Procedure","longName":"3308097","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2045A13-8290-ADB5-E040-BB89AD4374D9","latestVersionIndicator":"Yes","beginDate":"2011-11-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-11-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2045A13-82A9-ADB5-E040-BB89AD4374D9","beginDate":"2011-11-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-11-18","modifiedBy":"ONEDATA","dateModified":"2011-11-18","deletedIndicator":"No"},{"value":"Progressive disease","valueDescription":"Progressive disease","ValueMeaning":{"publicId":"3308127","version":"1","preferredName":"Progressive disease","longName":"3308127","preferredDefinition":"Any new lesion; increase of any measurable lesion by greater than or equal to 25 percent; previously negative bone marrow positive for tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2045A13-82C6-ADB5-E040-BB89AD4374D9","latestVersionIndicator":"Yes","beginDate":"2011-11-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-11-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2045A13-82DE-ADB5-E040-BB89AD4374D9","beginDate":"2011-09-15","endDate":null,"createdBy":"NYCHM","dateCreated":"2011-11-18","modifiedBy":"ONEDATA","dateModified":"2011-11-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3278721","version":"1","preferredName":"Small Cell Lung Carcinoma Status Type","preferredDefinition":"A highly aggressive subtype of lung carcinoma characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.:A condition or state at a particular time.:Type; a subdivision of a particular kind of thing.","longName":"C4917:C25688:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Small Cell Carcinoma","conceptCode":"C4917","definition":"A highly aggressive carcinoma with neuroendocrine differentiation arising from the lung. It is characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD00CE93-1B5F-1C82-E040-BB89AD436E31","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"ONEDATA","dateModified":"2011-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD00CE93-1B70-1C82-E040-BB89AD436E31","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Released per Janet review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"3279255","version":"1","longName":"2121r1: Small Cell Lung Cancer Post-HSCT Data","context":"NHLBI"},{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"}]}],"AlternateNames":[{"name":"scl_post_dx_bst_rspn_kn","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the best outcome of","type":"Preferred Question Text","description":"What was the best outcome of therapy for small cell lung carcinoma?","url":null,"context":"NHLBI"},{"name":"What was the best response to HSCT?","type":"Alternate Question Text","description":"What was the best response to HSCT?","url":null,"context":"NHLBI"},{"name":"What was the best response of small cell lung carcinoma?","type":"Alternate Question Text","description":"What was the best response of small cell lung carcinoma?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD00CE93-1DB3-1C82-E040-BB89AD436E31","latestVersionIndicator":"Yes","beginDate":"2011-09-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-09-15","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Released per Janet review.  System generated def displayed as alt def. 2021-6-17 ak","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}